Cargando…
Rapidly progressive dementias — aetiologies, diagnosis and management
Rapidly progressive dementias (RPDs) are a group of heterogeneous disorders that include immune-mediated, infectious and metabolic encephalopathies, as well as prion diseases and atypically rapid presentations of more common neurodegenerative diseases. Some of these conditions are treatable, and som...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067549/ https://www.ncbi.nlm.nih.gov/pubmed/35508635 http://dx.doi.org/10.1038/s41582-022-00659-0 |
_version_ | 1784700029471031296 |
---|---|
author | Hermann, Peter Zerr, Inga |
author_facet | Hermann, Peter Zerr, Inga |
author_sort | Hermann, Peter |
collection | PubMed |
description | Rapidly progressive dementias (RPDs) are a group of heterogeneous disorders that include immune-mediated, infectious and metabolic encephalopathies, as well as prion diseases and atypically rapid presentations of more common neurodegenerative diseases. Some of these conditions are treatable, and some must be diagnosed promptly because of their potential infectivity. Prion disease is considered to be the prototypical RPD, but over the past two decades, epidemiological reports and the identification of various encephalitis-mediating antibodies have led to a growing recognition of other encephalopathies as potential causes of rapid cognitive decline. Knowledge of RPD aetiologies, syndromes and diagnostic work-up protocols will help clinicians to establish an early, accurate diagnosis, thereby reducing morbidity and mortality, especially in immune-mediated and other potentially reversible dementias. In this Review, we define the syndrome of RPD and shed light on its different aetiologies and on secondary factors that might contribute to rapid cognitive decline. We describe an extended diagnostic procedure in the context of important differential diagnoses, discuss the utility of biomarkers and summarize potential treatment options. In addition, we discuss treatment options such as high-dose steroid therapy in the context of therapy and diagnosis in clinically ambiguous cases. |
format | Online Article Text |
id | pubmed-9067549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90675492022-05-04 Rapidly progressive dementias — aetiologies, diagnosis and management Hermann, Peter Zerr, Inga Nat Rev Neurol Review Article Rapidly progressive dementias (RPDs) are a group of heterogeneous disorders that include immune-mediated, infectious and metabolic encephalopathies, as well as prion diseases and atypically rapid presentations of more common neurodegenerative diseases. Some of these conditions are treatable, and some must be diagnosed promptly because of their potential infectivity. Prion disease is considered to be the prototypical RPD, but over the past two decades, epidemiological reports and the identification of various encephalitis-mediating antibodies have led to a growing recognition of other encephalopathies as potential causes of rapid cognitive decline. Knowledge of RPD aetiologies, syndromes and diagnostic work-up protocols will help clinicians to establish an early, accurate diagnosis, thereby reducing morbidity and mortality, especially in immune-mediated and other potentially reversible dementias. In this Review, we define the syndrome of RPD and shed light on its different aetiologies and on secondary factors that might contribute to rapid cognitive decline. We describe an extended diagnostic procedure in the context of important differential diagnoses, discuss the utility of biomarkers and summarize potential treatment options. In addition, we discuss treatment options such as high-dose steroid therapy in the context of therapy and diagnosis in clinically ambiguous cases. Nature Publishing Group UK 2022-05-04 2022 /pmc/articles/PMC9067549/ /pubmed/35508635 http://dx.doi.org/10.1038/s41582-022-00659-0 Text en © Springer Nature Limited 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Hermann, Peter Zerr, Inga Rapidly progressive dementias — aetiologies, diagnosis and management |
title | Rapidly progressive dementias — aetiologies, diagnosis and management |
title_full | Rapidly progressive dementias — aetiologies, diagnosis and management |
title_fullStr | Rapidly progressive dementias — aetiologies, diagnosis and management |
title_full_unstemmed | Rapidly progressive dementias — aetiologies, diagnosis and management |
title_short | Rapidly progressive dementias — aetiologies, diagnosis and management |
title_sort | rapidly progressive dementias — aetiologies, diagnosis and management |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067549/ https://www.ncbi.nlm.nih.gov/pubmed/35508635 http://dx.doi.org/10.1038/s41582-022-00659-0 |
work_keys_str_mv | AT hermannpeter rapidlyprogressivedementiasaetiologiesdiagnosisandmanagement AT zerringa rapidlyprogressivedementiasaetiologiesdiagnosisandmanagement |